Pactiv Evergreen Q4 2023 Adj EPS $0.330 Beats $0.210 Estimate, Sales $1.274B Miss $1.319B Estimate
Portfolio Pulse from Benzinga Newsdesk
Pactiv Evergreen (PTVE) reported Q4 2023 adjusted EPS of $0.330, surpassing the $0.210 estimate by 57.14%, but its sales of $1.274B fell short of the $1.319B estimate by 3.38%. This represents a 13.69% decrease in sales compared to the same period last year.
February 29, 2024 | 9:21 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pactiv Evergreen reported a strong Q4 2023 EPS of $0.330, beating estimates, but missed on sales with $1.274B versus the expected $1.319B.
While PTVE's EPS beat may positively impact investor sentiment due to better-than-expected profitability, the miss on sales forecasts and the significant year-over-year sales decline could temper any potential stock price gains. The mixed results present a neutral short-term outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100